In adults with Friedreich’s ataxia (FA), a brain communication pathway connecting the cerebellum to the motor cortex, which coordinates and controls movement, showed signs of tissue shrinkage, disrupted brain signaling, and reduced energy production on MRI scans. According to the imaging study, FA-related changes across the so-called dentato-thalamo-cortical…
News
Following feedback from the U.S. Food and Drug Administration (FDA), Larimar Therapeutics is on track to soon submit an application seeking accelerated approval — which gets a drug to patients but still requires additional testing — of nomlabofusp, its protein replacement therapy for Friedreich’s ataxia (FA). Larimar recently…
Abnormal buildup of iron in mitochondria, the powerhouses of cells, may contribute to heart damage in Friedreich’s ataxia, according to a new study done in a mouse model. Data also indicate that heart cells have reduced ability to recycle damaged mitochondria in Friedreich’s ataxia. Collectively, the findings shed new…
Skyclarys (omaveloxolone) improved key measures of function and cellular health in nerve cells from the dorsal root ganglia, clusters of sensory nerve cells next to the spinal cord that are affected early in Friedreich’s ataxia (FA), according to a cell-based study. The researchers also found that combining low…
Scientists at the University of Oxford are embarking on five pioneering research projects — together backed by more than half a million dollars in funding — that aim to advance the discovery of new treatments for Friedreich’s ataxia (FA). The new projects are being funded by the Oxford-Harrington Rare…
Researchers have developed a new type of gene therapy that, according to the findings of a new study in animal models, may correct both nerve and heart problems in people with Friedreich’s ataxia (FA). The one-time treatment, administered via a spinal tap, was designed to simultaneously target the heart…
Sensors worn while walking at a natural pace can accurately distinguish people with Friedreich’s ataxia (FA) from those without the disease, according to a study. Data from these sensors also showed that FA patients with greater step-to-step variability and irregular trunk movements during walking had more severe disease. “Digital…
High-resolution nerve ultrasound revealed nerve enlargement, a sign of nerve changes, in the arms and legs of people with Friedreich’s ataxia (FA), a study in Germany shows. The study also found that some people showed nerve atrophy, or shrinkage, in the arms and legs. Together, the findings highlight that…
The first patient has been dosed in a small study testing SGT-212, a gene therapy candidate being developed by Solid Biosciences for people with Friedreich’s ataxia (FA). The dose-finding Phase 1b FALCON trial (NCT07180355) — a first-in-human study being conducted at two sites in the U.S. —…
The team at Friedreich’s Ataxia News spent 2025 bringing readers the latest updates on research, treatments, and clinical trials related to the rare inherited disease. From long-term real-world outcomes with approved therapies to promising steps toward gene therapy, this year delivered meaningful progress for the Friedreich’s ataxia (FA)…
Recent Posts
- How I field the question, ‘Why are you in a wheelchair?’
- Scientists link shrinkage of key brain pathway to FA motor symptoms
- My to-do list always looms, but self-compassion helps me manage
- How FA influenced our decision when it was time to buy a car
- I shed the ‘How does she do it?’ dream to be a helpful person who needs help